Cargando…
Two cases of Erythrodermic psoriasis treated with Golimumab
INTRODUCTION AND IMPORTANCE: Erythrodermic psoriasis (EP) is a very severe subtype of psoriasis, with a challenge poses in its treatment, as currently available therapies often provide unsatisfactory results, for those many biologics have been used in the treatment of EP such as Golimumab which has...
Autores principales: | Kudsi, Mayssoun, Alzabibi, Mhd Amin, Shibani, Mosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207129/ https://www.ncbi.nlm.nih.gov/pubmed/35734731 http://dx.doi.org/10.1016/j.amsu.2022.103961 |
Ejemplares similares
-
Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015) -
Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus, Syria
por: Alzabibi, Mhd Amin, et al.
Publicado: (2022) -
Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
por: Chiang, Cheng-Ying, et al.
Publicado: (2021) -
Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016) -
Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
por: Pangilinan, Mary Catherine G., et al.
Publicado: (2020)